Protein L Protein (Biotin)
Kurzübersicht für Protein L Protein (Biotin) (ABIN1536530)
Target
Alle Protein L Proteine anzeigenSpezies
Wirt
Applikation
-
-
Aufreinigungstag / Konjugat
- Dieses Protein L Protein ist gelabelt mit Biotin.
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Applikationshinweise
- Working concentrations for specific applications should be determined by titration assay. The chart below may serve as a useful guideline, but primary antibody, temperature, incubation time, the amount of antigen, and the sensitivity of the detection methods can all affect the ideal working concentration. Dot blot: 1:2,000-1:20,000 Western blot: 1:2,000-1:20,000 ELISA: 1:20,000-1:100,000 Other: user-optimized
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute the lyophilized product with deionized water (or equivalent) to the final concentration of 1.0 mg/ml.
-
Konzentration
- 1 mg/ml
-
Buffer
- PBS (pH 7.4) containing 10 mg/ml BSA and 0.02% sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- The product is stable in lyophilized form if stored at -20°C or below. The reconstituted product can be stored for 2-3 weeks at 2-8°C. For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.
-
-
-
: "Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice." in: BMC cancer, Vol. 14, pp. 30, (2014) (PubMed).
: "A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer." in: Human gene therapy, Vol. 25, Issue 12, pp. 1003-12, (2014) (PubMed).
: "Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor." in: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 20, Issue 3, pp. 633-43, (2012) (PubMed).
: "Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma." in: Human gene therapy, Vol. 23, Issue 10, pp. 1043-53, (2012) (PubMed).
-
: "Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice." in: BMC cancer, Vol. 14, pp. 30, (2014) (PubMed).
-
- Protein L
-
Hintergrund
- Protein L is a cell surface protein from Peptostreptoccocus magnus that binds to the variable light chains (kappa chain) of immunoglobulins without interfering with antigen binding. In contrast to IgG-binding proteins, such as protein A and protein G, protein L can be used for the detection and purification of mammalian kappa light chain antibodies of all classes. Biotin-Protein L, which is produced by covalently linking biotin to protein L, can be used in immunodetections, such as immunoblotting (western or dot blot), ELISA, and immunohistochemistry.
Target
-